Work

Phase II trial of the dual IGF-1R/IR inhibitor BMS-754807 with or without letrozole in aromatase inhibitor-resistant breast cancer.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.tps111

Authors: P. Haluska, A. Dhar, X. Hou, F. Huang, D. S. A. Nuyten, J. Park, A. H. Brodie, J. N. Ingle, J. M. Carboni, M. M. Gottardis, A. C. Wolff, F. G. Finckenstein

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2564563836

Cites:

Cited by: 12

Related to: 10